HYDROCORTISONE IN ABSORBASE Drug Patent Profile
✉ Email this page to a colleague
When do Hydrocortisone In Absorbase patents expire, and when can generic versions of Hydrocortisone In Absorbase launch?
Hydrocortisone In Absorbase is a drug marketed by Cmp Pharma Inc and is included in one NDA.
The generic ingredient in HYDROCORTISONE IN ABSORBASE is hydrocortisone. There is one drug master file entry for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocortisone In Absorbase
A generic version of HYDROCORTISONE IN ABSORBASE was approved as hydrocortisone by IMPAX LABS INC on March 30th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYDROCORTISONE IN ABSORBASE?
- What are the global sales for HYDROCORTISONE IN ABSORBASE?
- What is Average Wholesale Price for HYDROCORTISONE IN ABSORBASE?
Summary for HYDROCORTISONE IN ABSORBASE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Patent Applications: | 4,519 |
| DailyMed Link: | HYDROCORTISONE IN ABSORBASE at DailyMed |
US Patents and Regulatory Information for HYDROCORTISONE IN ABSORBASE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cmp Pharma Inc | HYDROCORTISONE IN ABSORBASE | hydrocortisone | OINTMENT;TOPICAL | 088138-001 | Sep 6, 1985 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for HYDROCORTISONE IN ABSORBASE
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals International AG Ireland Branch | Plenadren | hydrocortisone | EMEA/H/C/002185Treatment of adrenal insufficiency in adults. | Authorised | no | no | no | 2011-11-03 | |
| Diurnal Europe B.V. | Alkindi | hydrocortisone | EMEA/H/C/004416Replacement therapy of adrenal insufficiency in infants, children and adolescents (from birth to < 18 years old). | Authorised | no | no | no | 2018-02-09 | |
| Diurnal Europe B.V. | Efmody | hydrocortisone | EMEA/H/C/005105Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults. | Authorised | no | no | no | 2021-05-27 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
